Anandamide exerts its antiproliferative actions on cholangiocarcinoma by activation of the GPR55 receptor

Cholangiocarcinomas are devastating cancers of biliary origin with limited treatment options. It has previously been shown that the endocannabinoid anandamide exerts antiproliferative effects on cholangiocarcinoma independent of any known cannabinoid receptors, and via the stabilization of lipid raf...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Li, Ramirez, Jonathan, Frampton, Gabriel A, Golden, Lessie E, Quinn, Matthew A, Pae, Hae Yong, Horvat, Darijana, Liang, Li-jian, DeMorrow, Sharon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2011
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3126905/
https://www.ncbi.nlm.nih.gov/pubmed/21464819
http://dx.doi.org/10.1038/labinvest.2011.62

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3126905/
https://www.ncbi.nlm.nih.gov/pubmed/21464819
http://dx.doi.org/10.1038/labinvest.2011.62

Ejemplares similares